India Laboratory Equipment Market Size, Share & Industry Analysis, By Product Type (Analytical Equipment, General Equipment, Specialty Equipment, and Support Equipment), By Application (Pharmaceutical and Biopharmaceutical Companies, Clinical & Diagnostic Laboratories, Academic & Research Institutes, and Veterinary), and Country Forecast, 2026-2034

The India laboratory equipment market size was valued at USD 1.17 billion in 2025 and is projected to grow from USD 1.25 billion in 2026 to USD 1.93 billion by 2034, exhibiting a CAGR of 5.6% during the forecast period.

Laboratory equipment refers to the specialized tools, apparatus, and instruments used for measurements, conducting experiments, and analyzing substances in research laboratories, clinical facilities, and institutes. Increasing prevalence of chronic and infectious conditions, number of diagnostic tests, and growing healthcare spending are supporting the penetration of laboratory equipment  in the market.

• For instance, according to the 2024 statistics published by the World Health Organization (WHO), about 77 million people aged 18 years or older have Type 2 diabetes in India.

Furthermore, rising investments in diagnostic outreach and regional pharma manufacturing and growing technological advancements in these systems by prominent players, including Thermo Fisher Scientific Inc., and Agilent Technologies, Inc., among others, are further contributing to the demand for these products in the market.

India Laboratory Equipment Market Trends

Technological Advancements in these Systems to Fuel the Demand in the Market

There is an increasing emphasis on the integration of technological advancements into laboratory equipment across public health, research laboratories, and diagnostic labs, which reduces manual intervention and improves biosafety. The key companies are focusing on technologically advanced devices, such as the automation-enabled instruments and others, which are important in high-burden disorder environments and regulated testing facilities.

Moreover, newer laboratory equipment integrates real-time monitoring, data traceability, and connectivity features that support compliance with accreditation requirements. Therefore, growing technological advancements such as compact devices and scalable laboratory equipment solutions have become one of the prominent trends in the India laboratory equipment market.

• For instance, in October 2025, FUJIFILM Corporation launched its FW500 Clinical Chemistry Analyzer with an aim to strengthen FUJIFILM India’s In-vitro diagnostics portfolio.

Download Free sample to learn more about this report.

Market Dynamics

Market Drivers

Rising Burden of Chronic Diseases to Drive Market Growth

The increasing prevalence of chronic diseases, including infectious and other disorders, further results in a growing number of diagnostic procedures among the patient population, consequently boosting the demand for laboratory equipment among research professionals.

• For instance, according to statistics published by the Global TB Report, about 2.8 million people were estimated to have been newly affected with tuberculosis in the year 2023 in India.

This, coupled with the increasing demand in Indian states such as Maharashtra, Karnataka, Telangana, Tamil Nadu, and Gujarat, and research and development activities to study the potential candidates among the pharmaceutical and biotechnological companies, is further augmenting the adoption rate of these systems. Therefore, the above-mentioned factors, coupled with the rising focus of key companies on R&D activities to introduce novel devices, are expected to boost the adoption rate of these devices, thereby contributing to the the India laboratory equipment market growth.

Other Prominent Drivers

• Expansion of diagnostics capacity and private lab networks across India.
• Growing domestic pharmaceutical manufacturing and export-oriented generic drug production.
• Government support for life‑sciences manufacturing (PLI and related schemes) and increased R&D spending.

Market Restraints

High Cost of These Laboratory Equipment to Hinder the Market Growth

The high cost associated with technologically advanced laboratory equipment hinders their penetration rate in the market.

The advanced devices, such as analyzers, ultra-low temperature freezers, advanced biosafety infrastructure, and others, involve substantial upfront cost coupled with recurring maintenance costs, installation costs, and skilled manpower, which makes it challenging for smaller hospitals and laboratories to adopt these advanced products. These ongoing costs result in delayed upgrades or extended use of laboratory equipment beyond their replacement cycles, thereby limiting their adoption rate and hampering the market growth.

• For instance, according to the 2024 statistics published by Excedr, Labconco’s biosafety cabinets range from USD 6,000 to USD 15,000

Market Opportunities

Increasing Number of CROs and CDMOs to Create Market Growth Aspects

There is a rapid expansion of Contract Development And Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and broader contract research activity in India. The increasing demand for outsourcing research, development, and manufacturing services is consequently increasing the adoption of laboratory equipment in healthcare settings.

This is driving the biotechnology, pharmaceutical, and life sciences companies to increasingly engage with CDMOs and CROs for the development of formulations, bioanalytical services, clinical trial support, and specialized testing, resulting in growing demand for advanced laboratory instruments covering molecular assays, analytical testing, bioprocessing support, and quality control workflows.

• According to 2026 statistics published by Cliniminds, it was reported that there are more than 100 international and Indian Contract Research Organizations (CROs) in India.

Market Challenges

Regulatory Barriers to Limit the Market Growth

There are growing advantages of technologically advanced lab equipment, resulting in penetration rate for these systems. However, the stringent regulatory framework for these devices is one factor limiting the adoption rate of these products.

The laboratory equipment is subjected to various standards by regulatory authorities requiring documentation, licensing, and periodic compliance with safety and high-quality standards. Navigating these regulatory policies can be time-consuming and complex, particularly for new product launches, imported devices, and smaller companies with limited regulatory expertise. Therefore, the increasing stringency in regulatory laws can make it challenging for smaller companies and clinical facilities to adopt these products, thereby hampering the adoption rate of these products.

• Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare (MoHFW), is the nodal regulatory authority for laboratory equipment that falls under the Medical Devices Rules (MDR).

Other Prominent Challenges

• Supply-chain dependence on imports for high-end capital instruments; trade and forex risks.
• Need for skilled technicians and after-sales service networks outside major metros.

SEGMENTATION ANALYSIS

By Product Type

Increasing Product Launches Led to the Analytical Equipment Segment’s Dominance

Based on the product type, the market is classified into analytical equipment, general equipment, specialty equipment, and support equipment.

The analytical equipment segment held the largest revenue share in 2025. The growth is due to the increasing prevalence of chronic disorders among the patient population and rising number of diagnostic tests. This, along with the growing focus of key players on launching innovative devices, is further expected to support the overall market growth.

• For instance, in July 2025, Agilent Technologies, Inc., launched its highly anticipated InfinityLab Pro iQ Seriesmass detectors, designed for next-generation liquid chromatography–mass spectrometry (LC-MS), the Pro iQ Series in India.

The specialty equipment segment is the fastest growing segment and expected to grow at a CAGR of 6.3% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Increasing Number of Clinical & Diagnostic Testing Laboratories Led to their Segmental Dominance

Based on application, the market is segmented into pharmaceutical & biopharmaceutical companies, clinical & diagnostic laboratories, academic & research institutes, and veterinary.

The clinical & diagnostic laboratories segment dominated the India laboratory equipment market share in 2025. The increasing volume of diagnostic tests, rising number of clinical & diagnostic laboratories, among others, are some of the vital factors supporting the growth of the segment in the market. Furthermore, the segment is set to hold a 46.4% share in 2026.

• According to 2025 data published by IAS Score, it was reported that there are about 300,000 diagnostic labs in India.

In addition, pharmaceutical & biopharmaceutical companies are projected to grow at a 5.8% CAGR during the forecast period.

Competitive Landscape

Key Industry Players

Growing Number of New Product Launches by the Prominent Market Players to Support Their Market Positions

A significant product portfolio, along with a significant emphasis on strategic initiatives, are some  of the prominent factors contributing to the dominance of these players in the market. Thermo Fisher Scientific Inc. and Agilent Technologies, Inc., are major companies in the market in 2025. Additionally, the increasing focus of key companies on the establishment of new biopharma centres to support the R&D activities is likely to strengthen their presence and further support their market shares.

• In August 2025, Agilent Technologies, Inc., inaugurated a Biopharma Experience Centre to support advanced R&D workflows in chromatography, mass spectrometry, cell analysis, and lab informatics. The hub aims to foster academia–industry collaboration and boost life sciences innovation in India.

Other key players, including Sartorius AG are also growing in the market, primarily owing to their growing focus on inorganic growth strategies through attending conferences.

List of Key India Laboratory Equipment Companies Profiled

• Thermo Fisher Scientific, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Sartorius AG (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Avantor, Inc. (U.S.)
• Toshvin (India)
• Accumax Lab Devices Pvt Ltd (India)
• ELECTROLAB INDIA PVT. LTD. (India)
• Sai Scientific Instruments (India)
• Borosil Scientific (India)

KEY INDUSTRY DEVELOPMENTS

• December 2025: The PharmaTech Expo & LabTech Expo was held with the Indian Pharmaceutical Congress (IPC) 2025 in Bengaluru, India. The events focused on showcasing the latest laboratory instrumentation, such as analytical solutions, biotechnology innovations, and collaborative technologies designed to advance pharmaceutical and research workflows.
• October 2025: Thermo Fisher Scientific, Inc., invested USD 20.0 million to expand its Bengaluru facility. The expansion supports the advanced automation platforms for immunoassays, protein analysis, and cell-based studies.
• October 2025: VFL Sciences launched the GreatFlo PBR, laboratory Photo Bioreactors during the IKMC 2025 exhibition at Hyderabad, India. The company's photo bioreactors have been designed with a focus on customers to deliver a state-of-the-art instrument that fits comfortably on a lab bench.
• September 2025: Labindia Instruments showcased and launched an innovative Ductless Fume Hood at the Analytica Lab India Exhibition held in Hyderabad, India. This equipment represents a significant improvement in laboratory safety technology and sustainable airflow management without external ducting, helping labs enhance ventilation and protection in space-constrained environments. This launch was part of Labindia’s focus on next-generation lab infrastructure solutions.
• October 2024: Thermo Fisher Scientific Inc., launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).
• June 2024 – VFL Sciences, launched GreatSpin range of centrifuges. This is the first range of centrifuge from VFL Sciences and the company is planning to launch several other models in the upcoming years.
• November 2022 – Haier Biomedical launched Mini and Dual Exhaust Filter Model HR700-IIA2 and HR900-IIA2-D biological safety cabinets with an aim to strengthen its product portfolio.

REPORT COVERAGE

The market report provides a detailed India laboratory equipment market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, and application. Besides this, the India report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation